Opinion 25 - EPHA

Exchange of views with the Special Committee on COVID-19 pandemic — Speech

by European Public Health Alliance | Sep 7, 2022 | Opinion

Thanks to the European Parliament Special Committee on the COVID-19 pandemic for this opportunity to share our feedback. We believe that meaningful engagement with civil society is key to strengthen democratic processes and improve policymaking. The European Public...

Health costs from air pollution: Bulgarian civil society to close a polluting thermal power plant

by European Public Health Alliance | Aug 31, 2022 | Opinion

Guest article by Reneta Ilieva, International Projects Coordinator, BAPD Air pollution continues to have significant impacts on the health of Europeans, particularly in Bulgaria. We see a severe lag compared to other countries in the European Union in terms of air...

Fluorinated gases regulation and climate warming

by European Public Health Alliance | Aug 31, 2022 | Opinion

Guest article by Marta Montanari, Policy and Events Officer at the European Respiratory Society In 2020, the European Commission started to work on a new initiative to update the current set of rules to reduce Fluorinated gases (F-gases) emissions. There are four...

The WHO Air Quality Guidelines should be used to set air pollution reduction targets in our cities

by European Public Health Alliance | Aug 31, 2022 | Opinion

Guest article by Dr Alessandro Borgini, ISDE – Italy Decades of important scientific studies have revealed the strong connection between exposure to air pollution and adverse health outcomes like respiratory infections, heart disease and lung cancer. Both...

When open letters work: publication of the EU proposal on pollution emission standards for vehicles

by European Public Health Alliance | Aug 31, 2022 | Opinion

The European Public Health Alliance (EPHA), the European Respiratory Society (ERS), the European Environmental Bureau (EEB), Transport & Environment, and POLIS Network, co-signed a letter on 30 June asking the European Commission to not postpone the release of its...

Tackling immunoglobulins shortages through a multi-stakeholder approach

by European Public Health Alliance | Aug 29, 2022 | Opinion

Guest article by Robin Doeswijk and Gauthier Quinonez, European Hematology Association Plasma Shortages Plasma-derived medicinal products (PDMPs) are used to treat various rare, chronic, and potentially life-threatening conditions including immune deficiencies,...